Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
36.50
-2.95 (-7.48%)
Jul 16, 2026, 4:00 PM EDT - Market closed
Neurogene Market Cap
Neurogene has a market cap or net worth of $727.33 million as of July 16, 2026. Its market cap has increased by 137.53% in one year.
Market Cap
727.33M
Enterprise Value
493.28M
1-Year Change
137.53%
Ranking
Category
Stock Price
$36.50
ChartMarket Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $727.33M, an increase of 275.61%. That is a compound annual growth rate of 67.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 727.33M | 127.94% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 796.79M |
| Tenax Therapeutics | 794.99M |
| Oculis Holding AG | 780.82M |
| Aura Biosciences | 772.10M |
| Zevra Therapeutics | 772.04M |
| Rigel Pharmaceuticals | 761.73M |
| Immix Biopharma | 760.31M |
| Omeros | 759.94M |